Ocular Therapeutix Gross Profit 2013-2019 | OCUL

Ocular Therapeutix gross profit from 2013 to 2019. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
Ocular Therapeutix Annual Gross Profit
(Millions of US $)
2018 $2
2017 $1
2016 $1
2015 $1
2014 $1
2013 $
2012 $0
Ocular Therapeutix Quarterly Gross Profit
(Millions of US $)
Q3 2019 $0
Q2 2019 $0
Q1 2019 $0
Q4 2018 $0
Q3 2018 $0
Q2 2018 $0
Q1 2018 $0
Q4 2017 $0
Q3 2017 $0
Q2 2017 $0
Q1 2017 $0
Q4 2016 $0
Q3 2016 $0
Q2 2016 $0
Q1 2016 $0
Q4 2015 $0
Q3 2015 $0
Q2 2015 $0
Q1 2015 $0
Q4 2014 $0
Q3 2014 $0
Q2 2014 $0
Q1 2014 $0
Q4 2013
Q3 2013
Q2 2013
Q4 2012
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.135B $0.002B
Ocular Therapeutix, Inc. is a biopharmaceutical company. It is focused on the development and commercialization of ophthalmic therapeutic products using its proprietary hydrogel technology to address unmet or underserved needs in ophthalmology. The Company develops and markets eye care products. Ocular Therapeutix, Inc. is headquartered in Bedford, Massachusetts.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $64.930B 10.26
Zoetis (ZTS) United States $57.313B 34.28
Astellas Pharma (ALPMY) Japan $31.713B 15.84
Eisai (ESALY) Japan $20.263B 39.07
UCB SA (UCBJF) Belgium $15.697B 0.00
Merck (MKGAF) Germany $15.483B 21.13
Grifols, S.A (GRFS) Spain $15.250B 19.46
Neurocrine Biosciences (NBIX) United States $10.382B 490.13
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
IPSEN SA ADR (IPSEY) France $9.043B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.638B 0.00
Ionis Pharmaceuticals (IONS) United States $8.171B 16.55
Jazz Pharmaceuticals (JAZZ) Ireland $7.858B 10.04
Sage Therapeutics (SAGE) United States $7.667B 0.00
Catalent (CTLT) United States $7.478B 30.42
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.263B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
STADA ARZNEIMI (STDAF) Germany $5.375B 0.00
Hypermarcas (HYPMY) Brazil $5.014B 18.02
Arrowhead Pharmaceuticals (ARWR) United States $4.788B 109.78
United Therapeutics (UTHR) United States $4.060B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.428B 12.53
FibroGen (FGEN) United States $3.285B 96.54
Nektar Therapeutics (NKTR) United States $3.221B 0.00
Evotec AG (EVTCY) Germany $3.079B 50.38
PTC Therapeutics (PTCT) United States $2.766B 0.00
Portola Pharmaceuticals (PTLA) United States $2.270B 0.00
Xencor (XNCR) United States $2.140B 65.05
Heron Therapeutics (HRTX) United States $2.089B 0.00
Zogenix (ZGNX) United States $2.022B 0.00
Tilray (TLRY) Canada $2.003B 0.00
Corcept Therapeutics (CORT) United States $1.938B 23.56
Ironwood Pharmaceuticals (IRWD) United States $1.803B 57.50
Pacira Pharmaceuticals (PCRX) United States $1.791B 52.99
USANA Health Sciences (USNA) United States $1.568B 16.73
CLINIGEN GP (CLIGF) United Kingdom $1.244B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.238B 20.42
Radius Health (RDUS) United States $1.135B 0.00
ArQule (ARQL) United States $1.021B 0.00
Endo (ENDP) Ireland $1.009B 1.85
Theravance Biopharma (TBPH) Cayman Islands $0.991B 0.00
Karyopharm Therapeutics (KPTI) United States $0.980B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.949B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.909B 6.20
Aerie Pharmaceuticals (AERI) United States $0.874B 0.00
Organogenesis Holdings (ORGO) United States $0.754B 0.00
TherapeuticsMD (TXMD) United States $0.702B 0.00
Translate Bio (TBIO) United States $0.639B 0.00
Collegium Pharmaceutical (COLL) United States $0.638B 0.00
Flexion Therapeutics (FLXN) United States $0.628B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.573B 0.00
Concordia (CXRXF) Canada $0.552B 0.00
ImmunoGen (IMGN) United States $0.521B 0.00
ChemoCentryx (CCXI) United States $0.505B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.465B 56.38
Aptorum Group (APM) Hong Kong, SAR China $0.457B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.449B 0.00
Ardelyx (ARDX) United States $0.445B 0.00
OptiNose (OPTN) United States $0.440B 0.00
Dermira (DERM) United States $0.439B 0.00
Siga Technologies (SIGA) United States $0.412B 9.41
BioSpecifics Technologies Corp (BSTC) United States $0.394B 16.98
Recro Pharma (REPH) United States $0.383B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.380B 0.00
Akebia Therapeutics (AKBA) United States $0.378B 0.00
Lannett Co Inc (LCI) United States $0.363B 4.23
Harpoon Therapeutics (HARP) United States $0.360B 0.00
DURECT (DRRX) United States $0.360B 0.00
Indivior (INVVY) United States $0.355B 1.28
Innate Pharma SA (IPHYF) France $0.340B 0.00
Molecular Templates (MTEM) United States $0.300B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.287B 0.00
Rafael Holdings (RFL) United States $0.282B 0.00
GlycoMimetics (GLYC) United States $0.264B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.224B 0.00
Xeris Pharmaceuticals (XERS) United States $0.216B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.208B 0.00
Calithera Biosciences (CALA) United States $0.208B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.207B 0.00
KalVista Pharmaceuticals (KALV) United States $0.203B 0.00
Nature's Sunshine Products (NATR) United States $0.188B 32.50
Avadel Pharmaceuticals (AVDL) Ireland $0.180B 0.00
Jounce Therapeutics (JNCE) United States $0.170B 2.28
Concert Pharmaceuticals (CNCE) United States $0.162B 0.00
Taiwan Liposome (TLC) Taiwan $0.162B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.158B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.139B 0.00
Aquestive Therapeutics (AQST) United States $0.136B 0.00
Redhill Biopharma (RDHL) Israel $0.132B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.130B 0.00
MEI Pharma (MEIP) United States $0.130B 0.00
CV Sciences (CVSI) United States $0.122B 0.00
CannTrust Holdings (CTST) Canada $0.119B 0.00
IMV INC (IMV) Canada $0.116B 0.00
Cardiome Pharma (CORV) Canada $0.111B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.096B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.090B 0.00
MediWound (MDWD) Israel $0.085B 0.00
Majesco Entertainment (PTE) United States $0.083B 0.00
Neos Therapeutics (NEOS) United States $0.077B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.075B 22.41
Otonomy (OTIC) United States $0.074B 0.00
Aclaris Therapeutics (ACRS) United States $0.073B 0.00
Pharmaxis (PXSLY) Australia $0.068B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.066B 0.00
SCYNEXIS (SCYX) United States $0.065B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.064B 0.00
Generex Biotechnology (GNBT) United States $0.062B 0.00
Infinity Pharmaceuticals (INFI) United States $0.060B 0.00
Champions Oncology (CSBR) United States $0.060B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.059B 0.00
Natural Alternatives (NAII) United States $0.059B 14.59
Genocea Biosciences (GNCA) United States $0.058B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.057B 0.00
Medicure (MCUJF) Canada $0.056B 0.00
RENEURON GP (RNUGF) United Kingdom $0.054B 0.00
AgeX Therapeutics (AGE) United States $0.054B 0.00
Novan (NOVN) United States $0.053B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.050B 0.00
Nivalis Therapeutics (ALPN) United States $0.048B 0.00
Capnia (SLNO) United States $0.048B 0.00
ElectroCore (ECOR) United States $0.046B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.045B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.043B 0.00
CTI BioPharma (CTIC) United States $0.042B 0.00
Forward Pharma (FWP) Denmark $0.040B 0.00
Mast Therapeutics (SVRA) United States $0.037B 0.00
Mannatechorporated (MTEX) United States $0.037B 0.00
Opexa Therapeutics (ACER) United States $0.033B 0.00
India Globalization Capital (IGC) United States $0.031B 0.00
Iterum Therapeutics (ITRM) Ireland $0.030B 0.00
Biomerica (BMRA) United States $0.030B 0.00
Jaguar Animal Health (JAGX) United States $0.030B 0.00
Bio-Path Holdings (BPTH) United States $0.028B 0.00
IsoRay (ISR) United States $0.026B 0.00
China SXT Pharmaceuticals (SXTC) China $0.024B 0.00
PharmAthene (ALT) United States $0.023B 0.00
ProPhase Labs (PRPH) United States $0.023B 0.00
Melinta Therapeutics (MLNT) United States $0.020B 0.00
Heat Biologics (HTBX) United States $0.018B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.017B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.016B 0.00
Cyanotech (CYAN) United States $0.015B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Shineco (TYHT) China $0.014B 0.00
Regulus Therapeutics (RGLS) United States $0.013B 0.00
Flex Pharma (SLRX) United States $0.012B 0.00
HANCOCK JAFFE (HJLI) United States $0.010B 0.00
Lipocine (LPCN) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.008B 0.00
Vical (BBI) United States $0.007B 0.00
Achieve Life Sciences (ACHV) United States $0.007B 0.00
VAXART, INC (VXRT) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
RXi Pharmaceuticals (PHIO) United States $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
Onconova Therapeutics (ONTX) United States $0.002B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00
Hemispherx BioPharma (AIM) United States $0.001B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00